472 related articles for article (PubMed ID: 34751136)
1. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.
Song T; Song X; Zhu C; Patrick R; Skurla M; Santangelo I; Green M; Harper D; Ren B; Forester BP; Öngür D; Du F
Ageing Res Rev; 2021 Dec; 72():101503. PubMed ID: 34751136
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MRS Study.
Shukla D; Mandal PK; Mishra R; Punjabi K; Dwivedi D; Tripathi M; Badhautia V
J Alzheimers Dis; 2021; 84(3):1139-1152. PubMed ID: 34633325
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis.
Tumati S; Martens S; Aleman A
Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2571-86. PubMed ID: 23969177
[TBL] [Abstract][Full Text] [Related]
4. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
5. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of in vivo brain glutathione conformers in cingulate cortex among age-matched control, MCI, and AD patients using MEGA-PRESS.
Shukla D; Mandal PK; Tripathi M; Vishwakarma G; Mishra R; Sandal K
Hum Brain Mapp; 2020 Jan; 41(1):194-217. PubMed ID: 31584232
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
[TBL] [Abstract][Full Text] [Related]
8. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
9. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
Mandal PK; Saharan S; Tripathi M; Murari G
Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
[TBL] [Abstract][Full Text] [Related]
11. Altered central and blood glutathione in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
Chen JJ; Thiyagarajah M; Song J; Chen C; Herrmann N; Gallagher D; Rapoport MJ; Black SE; Ramirez J; Andreazza AC; Oh P; Marzolini S; Graham SJ; Lanctôt KL
Alzheimers Res Ther; 2022 Feb; 14(1):23. PubMed ID: 35123548
[TBL] [Abstract][Full Text] [Related]
12. Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease.
Mahapatra G; Gao Z; Bateman JR; Lockhart SN; Bergstrom J; DeWitt AR; Piloso JE; Kramer PA; Gonzalez-Armenta JL; Amick KA; Casanova R; Craft S; Molina AJA
Alzheimers Dement; 2023 Apr; 19(4):1466-1478. PubMed ID: 35870133
[TBL] [Abstract][Full Text] [Related]
13. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Waragai M; Moriya M; Nojo T
J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
Bradburn S; Murgatroyd C; Ray N
Ageing Res Rev; 2019 Mar; 50():1-8. PubMed ID: 30610927
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
[TBL] [Abstract][Full Text] [Related]
16. Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease and mild cognitive impairment.
Huang J
Front Immunol; 2022; 13():1010946. PubMed ID: 36211392
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment.
Kim J; Kim YK
Adv Exp Med Biol; 2023; 1411():301-326. PubMed ID: 36949316
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal investigation of neuroinflammation and metabolite profiles in the APP
Chaney A; Bauer M; Bochicchio D; Smigova A; Kassiou M; Davies KE; Williams SR; Boutin H
J Neurochem; 2018 Feb; 144(3):318-335. PubMed ID: 29124761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
